Positive reason for XBI - relatively equal weighted @ 1% - can not know which bio is going to be a winner! Like the 30 week moving average as an indicator. Thesis is as rates fall Bios will be more attractive! Supply of new drugs in big pharma is dwindling/ coming off patent and they need to replace with new drugs for revenue; so Big Parma will be looking to acquire some of the potential winners - AKA MDGL
การซื้อขายยังคงดำเนินอยู่
Still cruising sideways as rates got another boost!